Status:
NOT_YET_RECRUITING
A Low Dose Dexmedetomidine in Sedation Colonoscopy
Lead Sponsor:
West China Hospital
Conditions:
Colonoscopy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
104 patients who undergo painless colonoscopy from January 20,2024 to February 29,2024 will be randomized to two groups: propofol group and dexmedetomidine group. In the dexmedetomidine group,dexmede...
Detailed Description
104 patients who undergo painless colonoscopy from January 20,2024 to February 29,2024 will be randomized to two groups: propofol group and dexmedetomidine group. In the dexmedetomidine group,dexmede...
Eligibility Criteria
Inclusion
- Patients aged above 18 years
- American Society of Anesthesiologists (ASA) physical status of 1-2
- Patients scheduled for sedation colonoscopy
Exclusion
- Emergency patients
- Body weight \< 40 kg or \>100 kg
- Allergy to dexmedetomidine, propofol in this trail, a previous adverse reaction to dexmedetomidine or propofol
- Pregnancy or lactation
- Drug abusers
- Participation in other clinical studies within the previous 3 months
- renal impairment (glomerular filtration rate \< 60 ml/min), significant hepatic impairment (ascites, cirrhosis, or with international normalized ratio(INR) \>1.5)
Key Trial Info
Start Date :
January 20 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 29 2024
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT06208956
Start Date
January 20 2024
End Date
February 29 2024
Last Update
January 17 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.